Previous Close | 1.4100 |
Open | 1.3900 |
Bid | 0.9864 x 200 |
Ask | 1.7200 x 200 |
Day's Range | 1.3200 - 1.3900 |
52 Week Range | 1.2100 - 5.8200 |
Volume | |
Avg. Volume | 49,717 |
Market Cap | 46.423M |
Beta (5Y Monthly) | 1.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.6600 |
Earnings Date | Aug 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.63 |
Apyx Medical Corporation ( NASDAQ:APYX ), might not be a large cap stock, but it saw a double-digit share price rise of...
CLEARWATER, Fla., July 25, 2024--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that financial results for the second quarter of fiscal year 2024 will be released after the market closes on Thursday, August 8th.
Key Insights The projected fair value for Apyx Medical is US$1.64 based on 2 Stage Free Cash Flow to Equity Apyx...